Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

EQUITY (Narrative) (Details)

v3.23.1
EQUITY (Narrative) (Details)
$ / shares in Units, $ / shares in Units, ₪ in Thousands, $ in Millions
 1 Months Ended 12 Months Ended
Mar. 14, 2022
CAD ($)
$ / shares
shares
Mar. 14, 2022
ILS (₪)
May 10, 2021
CAD ($)
Shares
shares
May 10, 2021
USD ($)
Shares
$ / shares
Aug. 19, 2022
CAD ($)
shares
Aug. 19, 2022
USD ($)
shares
Mar. 28, 2022
CAD ($)
shares
Mar. 28, 2022
ILS (₪)
shares
Dec. 31, 2022
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2022
USD ($)
Shares
$ / shares
shares
Dec. 31, 2021
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2020
CAD ($)
Mar. 14, 2022
$ / shares
shares
May 10, 2021
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares                 7,569,526   6,811,620      
Proceeds from issuing shares                 $ 3,756,000   $ 28,131,000 $ 0    
Gross proceeds from warrants recorded as Share capital and premium                     11,832,000      
Transaction costs incurred for common share issuance                 178,000   3,800,000      
Proceeds from exercise of warrants and compensation options                 $ 0   $ 3,682,000 6,378,000    
Weighted average value of each option grant | $ / shares                 $ 10.85   $ 62      
Number of share options exercised | Shares                 22,705 22,705 51,735      
Exercise price of compensation option | $ / shares                 $ 16   $ 24.3      
Number of share options granted | Shares                 32,503 32,503 296,427      
Share-based compensation                 $ 2,637,000   $ 5,422,000 [1] $ 3,382,000    
Number of compensation warrants to acquired | shares                 18,261          
Warrant price per share | (per share)                 $ 84.2 $ 66.1        
Private Placement [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares         599,999 599,999     599,999          
Proceeds from issuing shares         $ 6,500,000 $ 5     $ 3,756,000 $ 3        
Transaction costs incurred for common share issuance         178,000       $ 178,000          
Gross proceeds from issuance of units         $ 6,500,000 $ 5                
Number of options exercised in cashless mechanism | shares                 1,873 1,873        
Number of options exercised in cashless mechanism to ordinary shares | shares                 904 904        
Pharm Yarok [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares 52,370                       52,370  
Par value per share | $ / shares $ 26.16                          
Proceeds from issuing shares $ 1,370,000                          
Vironna pharmacy [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares 48,536                       48,536  
Par value per share | (per share) $ 28.09                       $ 22.09  
Proceeds from issuing shares $ 1,360,000 ₪ 3,500                        
Oranim Pharm [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares             25,100 25,100            
Par value per share | (per share) $ 25.1                       $ 19.74  
Proceeds from issuing shares             $ 600,000 ₪ 1,536            
Overnight Marketed Offering [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares     608,696                      
Par value per share | $ / shares                           $ 57.5
Proceeds from issuing shares     $ 42,502,000 $ 35                    
Number of warrants issued for common shares | Shares     45,652 45,652                    
Expenses for share based compensation     $ 800,000                      
Number of share options granted | Shares     91,304 91,304                    
2021 Warrant [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of warrants issued for common shares | Shares     304,348 304,348                    
Exercise price of warrants issued per common share | $ / shares       $ 7.2                    
Number of common shares called by warrants | shares     304,348                      
Term of warrants     5 years 5 years                    
Gross proceeds from warrants recorded as Share capital and premium     $ 30,670,000                      
Warrant liability     11,832,000                      
Transaction costs incurred for common share issuance     3,800,000                      
2021 Warrant [Member] | Listed Warrants [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Transaction costs incurred for common share issuance     1,296,000                      
2021 Warrant [Member] | Share Capital [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Transaction costs incurred for common share issuance     $ 2,539,000                      
2018 Share Incentive Plan" (the "2018 Plan") [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Share-based compensation                 $ 2,637,000   5,422,000      
Number of shares available for future grants | shares                 299,650 299,650        
Weighted average fair value of each option grant                 $ 31.9   $ 41.6      
Weighted average remaining contractual life for the share options outstanding                 4 years 3 months 25 days 4 years 3 months 25 days 5 years 4 months 13 days      
2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest on the first anniversary of the applicable vesting commencement date [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Awards vest                 33.30% 33.30%        
2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest in eight equal installments upon the lapse of each three-month period thereafter [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Awards vest                 66.70% 66.70%        
[1] Reclassified in respect of discontinued operations - see Note 24.